Dermasectan

Dermasectan
Product Description

Dermasectan® is a patented medical device designed to manage and alleviate symptoms of Atopic Dermatitis. Clinically proven to offer similar efficacy to Hydrocortisone, it helps relieve dry, eczematous skin by maintaining a moist environment that supports the natural healing process. Its effectiveness is backed by both preclinical and clinical trials, including a study in children of 6 months of age.

Read more Show less

Devintec Pharma

  • CH
  • 2023
    On CPHI since
  • 1 - 24
    Employees
Company types
Pharmaceutical company
Primary activities
Finished Formulation products Distributor/Buyer
View company profile

Devintec Pharma

  • CH
  • 2023
    On CPHI since
  • 1 - 24
    Employees
Company types
Pharmaceutical company
Primary activities
Finished Formulation products Distributor/Buyer
View company profile

More Products from Devintec Pharma (4)

  • Gelsectan

    Product Gelsectan

    Gelsectan® is a patented medical device that restores intestinal function in patients experiencing irregular bowel movements due to Irritable Bowel Syndrome (IBS) related to intestinal hypersensitivity or medication use. It helps relieve and prevent symptoms like chronic or recurring diarrhea, abdominal di...
  • Gelselax

    Product Gelselax

    Gelselax® is a patented medical device specifically designed for patients with IBS-C or functional constipation. Clinical trials have shown that it delivers significant improvement in common symptoms such as constipation, abdominal pain, bloating, and flatulence, with noticeable results within just one wee...
  • Sectacol

    Product Sectacol

    Sectacol® is a patented medical device specifically designed to provide rapid and effective relief from functional bloating and abdominal distention within just 60 minutes. It works by forming a barrier that prevents gas-producing coliforms from adhering to the intestinal wall, reducing their proliferation...
  • Sorisen

    Product Sorisen

    Sorisen® is a patented medical device for patients with hyperkeratosis and skin plaques caused by mild to moderate Psoriasis (psoriasis vulgaris). It has been clinically proven to offer similar efficacy to Calcipotriol/Betamethasone in improving psoriasis symptoms.